The Association of Serum Follicle Stimulating Hormone and Hypercholesterolemia in Thai Peri and Postmenopausal Women. The Observational, Analytical Cross-sectional study.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20250311006

Enrollment

Registered

2025-03-11

Start date

2025-04-01

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypercholesterolemia Dyslipidemia Menopause Perimenopause Postmenopause Follicle-Stimulating Hormone Low-Density Lipoproteins Lipid Metabolism Cardiovascular Diseases Menopause Perimenopause Postmenopause Estradiol Aging Hormone Replacement Therapy

Interventions

The participants who has FSH level in first quartile,The participants who has FSH level in second quartile,The participants who has FSH level in third quartile,The participants who has FSH level in fo

Screening,Screening,Screening,Screening

FSH first Quartile,FSH second Quartile,FSH third Quartile,FSH fourth Quartile

Eligibility

Sex/Gender

Female

Age

40 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Thai women aged 40-60 years old 2.Natural or surgically induced menopause 3.Perimenopausal or early postmenopausal classified using STRAW+10 staging 4.Willingness to participate in the study

Exclusion criteria

Exclusion criteria: 1.Diagnosed metabolic syndrome before menopause 2.Pre-existing liver disease, familial hypercholesterolemia, thyroid disorders, or autoimmune diseases 3.Use of medications affecting lipid metabolism or menopause (e.g., statins, estrogen, progesterone, thyroid hormones, NSAIDs, beta-blockers) within the past three months 4.Patients already receiving hormone replacement therapy

Design outcomes

Primary

Measure	Time frame
LDL Cholesterol Level At baseline (Day 0) during participant's visit Direct LDL-C measurement (Enzymatic colorimetric method),Follicle Stimulating Hormone(FSH) At baseline (Day 0) during participant's visit electrochemiluminescence immunoassay (ECLIA),Association between serum Follicle-Stimulating Hormone (FSH) and Low-Density Lipoproteins (LDL-C) At baseline (Day 0) during participant's visit Analyze the correlation between serum FSH and LDL-C using Pearson correlation and multiple linear regression, adjusting for age, BMI, and blood pressure	—

Measure

Time frame

LDL Cholesterol Level At baseline (Day 0) during participant's visit Direct LDL-C measurement (Enzymatic colorimetric method),Follicle Stimulating Hormone(FSH) At baseline (Day 0) during participant's visit electrochemiluminescence immunoassay (ECLIA),Association between serum Follicle-Stimulating Hormone (FSH) and Low-Density Lipoproteins (LDL-C) At baseline (Day 0) during participant's visit Analyze the correlation between serum FSH and LDL-C using Pearson correlation and multiple linear regression, adjusting for age, BMI, and blood pressure

—

Secondary

Measure	Time frame
N/A This study is a cross-sectional study N/A	—

Countries

Thailand

Contacts

Public ContactUsanee Chulvuthinant

Dhurakij Pundit University

u.chulvuth@gmail.com0909655515

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026